Cabio Biotech (Wuhan) Co., Ltd. (688089.SS) SHH

Currency In CNY

AD

Cabio Biotech (Wuhan) Co., Ltd.

Address

No. 999 high-tech Avenue

Wuhan, 430073

China

Phone

86 27 6784 5351

Sector

Healthcare

Industry

Biotechnology

Employees

565

First IPO Date

December 19, 2019

Key Executives

NameTitlePayYear Born
Zhi Bo LiDeputy General Manager01973
Dewei YiChairman & GM01965
Huabiao WangFinancial Director & Director01965
Huarong YiDeputy GM & Secretary of the Board of Directors01976
Hao XiongAccounting Supervisor0N/A
Xiangyu LiDeputy General Manager01978
Anfeng GengDeputy General Manager01976
AD

Description

Cabio Biotech (Wuhan) Co., Ltd. focuses on the development, production, and worldwide distribution of crucial nutritional compounds such as arachidonic acid (ARA), docosahexaenoic acid (DHA), and beta-carotene. These ingredients are primarily supplied to manufacturers, both within China and internationally, who specialize in infant formula and healthy food products. The company's versatile offerings are incorporated into a wide array of goods, including infant nutritionals, health foods, dietary supplements, specialized medical purpose foods, pet food, commercial animal feed, and even personal care and cosmetic items. Founded in 1999, the company is headquartered in Wuhan, located in the People's Republic of China.

AD